H.U. Group Holdings, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3822000000
  • TKS: 4544
JPY
3,600.00
43 (1.21%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

172.9 k

Shareholding (Jun 2017)

FII

0.12%

Held by 1 FIIs

DII

99.88%

Held by 0 DIIs

Promoter

0.00%

iScoreScore

Dashboard

1

Weak Long Term Fundamental Strength with a -28.61% CAGR growth in Operating Profits over the last 5 years

 
2

Poor long term growth as Operating profit has grown by an annual rate -28.61% of over the last 5 years

 
3

The company has declared Positive results for the last 4 consecutive quarters

4

With ROCE of 3.12%, it has a very attractive valuation with a 1.32 Enterprise value to Capital Employed

5

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 192,255 Million (Small Cap)

stock-summary
P/E

27.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.11

stock-summary
Return on Equity

5.03%

stock-summary
Price to Book

1.40

Revenue and Profits:
Net Sales:
62,590 Million
(Quarterly Results - Jun 2026)
Net Profit:
1,547 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.57%
0%
12.57%
6 Months
15.53%
0%
15.53%
1 Year
2.19%
0%
2.19%
2 Years
33.33%
0%
33.33%
3 Years
35.54%
0%
35.54%
4 Years
34.88%
0%
34.88%
5 Years
13.39%
0%
13.39%

H.U. Group Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
2.09%
EBIT Growth (5y)
-28.61%
EBIT to Interest (avg)
38.50
Debt to EBITDA (avg)
0.97
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
1.16
Tax Ratio
21.87%
Dividend Payout Ratio
102.87%
Pledged Shares
0
Institutional Holding
0.12%
ROCE (avg)
10.14%
ROE (avg)
10.97%

Valuation key factors

Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
1.36
EV to EBIT
42.30
EV to EBITDA
7.62
EV to Capital Employed
1.32
EV to Sales
0.82
PEG Ratio
0.30
Dividend Yield
NA
ROCE (Latest)
3.12%
ROE (Latest)
5.03%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2017stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.12%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 3.23% vs -2.73% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 30.22% vs -77.89% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "62,590.00",
          "val2": "60,633.00",
          "chgp": "3.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7,166.00",
          "val2": "5,795.00",
          "chgp": "23.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "159.00",
          "val2": "167.00",
          "chgp": "-4.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-97.00",
          "val2": "-230.00",
          "chgp": "57.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,547.00",
          "val2": "1,188.00",
          "chgp": "30.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "33.60%",
          "val2": "9.90%",
          "chgp": "2.37%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 1.78% vs 2.56% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 145.48% vs 136.16% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "247,362.00",
          "val2": "243,025.00",
          "chgp": "1.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26,537.00",
          "val2": "23,092.00",
          "chgp": "14.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "686.00",
          "val2": "591.00",
          "chgp": "16.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-73.00",
          "val2": "-360.00",
          "chgp": "79.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6,704.00",
          "val2": "2,731.00",
          "chgp": "145.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.30%",
          "val2": "9.70%",
          "chgp": "0.96%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
62,590.00
60,633.00
3.23%
Operating Profit (PBDIT) excl Other Income
7,166.00
5,795.00
23.66%
Interest
159.00
167.00
-4.79%
Exceptional Items
-97.00
-230.00
57.83%
Consolidate Net Profit
1,547.00
1,188.00
30.22%
Operating Profit Margin (Excl OI)
33.60%
9.90%
2.37%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is 3.23% vs -2.73% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 30.22% vs -77.89% in Mar 2026

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
247,362.00
243,025.00
1.78%
Operating Profit (PBDIT) excl Other Income
26,537.00
23,092.00
14.92%
Interest
686.00
591.00
16.07%
Exceptional Items
-73.00
-360.00
79.72%
Consolidate Net Profit
6,704.00
2,731.00
145.48%
Operating Profit Margin (Excl OI)
19.30%
9.70%
0.96%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 1.78% vs 2.56% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 145.48% vs 136.16% in Mar 2025

stock-summaryCompany CV
About H.U. Group Holdings, Inc. stock-summary
stock-summary
H.U. Group Holdings, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Footer loading